跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lamitor 50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lamitor 50
Approved
STANDARD
Lamitor 50
TORRENT PHARMACEUTICALS LTD
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
214cacacf4606f4a
Company
TORRENT PHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
214cacacf4606f4a
Drug Approval Philippines Name
Lamitor 50
Product Name
Lamitor 50
Registration Number
DRP-2948
Brand Name
Lamitor 50
Generic Name
Lamotrigine
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
TORRENT PHARMACEUTICALS LTD
Importer
Torrent Pharma Philippines, Inc.
Distributor
Torrent Pharma Philippines, Inc.
Issuance Date
25 April 2022
Expiry Date
03 July 2027
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
214cacacf4606f4a
Type
Standard
Back to Philippines FDA Approvals